期刊
CARDIOLOGY IN THE YOUNG
卷 32, 期 7, 页码 1041-1047出版社
CAMBRIDGE UNIV PRESS
DOI: 10.1017/S1047951121003590
关键词
Dilated cardiomyopathy; endocardial fibroelastosis; heart failure; cardiac transplantation; paediatric
Heart failure caused by dilated cardiomyopathy is a common reason for pediatric cardiac transplantation. Endocardial fibroelastosis is a recognized pathology often found in pediatric dilated cardiomyopathy, especially in infants and young children. The presence of endocardial fibroelastosis was significantly higher in younger recipients, suggesting potential prognostic significance in this population.
Heart failure due to dilated cardiomyopathy is a major indication for paediatric cardiac transplantation. Endocardial fibroelastosis is a recognised pathological finding of unknown prognostic significance in paediatric dilated cardiomyopathy. To evaluate the nature of the association between left ventricular endocardial fibroelastosis and paediatric dilated cardiomyopathy, we reviewed surgical pathology reports of dilated cardiomyopathy explants (1986-2016) in order to characterise the pathological findings and to compare and contrast their frequency among four age groups: less than 1 year; 1-5 years; 6-10 years; and greater than 11 years. The 89 explants (47 males and 42 females) were all characterised by increased weight and left ventricular chamber dilatation without increased wall thickness. Ninety-five per cent of the specimens in the two youngest subsets had left ventricular endocardial fibroelastosis. Compared to the oldest age group, recipients aged 1-5 years had a 6-fold increase and those younger than 1 year a 19-fold increase in the odds of observing left ventricular endocardial fibroelastosis. Explants with and without endocardial fibroelastosis were otherwise phenotypically similar. In paediatric dilated cardiomyopathy endocardial fibroelastosis is a very common pathological finding, especially in infants and young children. We propose that the descriptive, clinico-pathological designation Dilated Cardiomyopathy with Endocardial Fibroelastosis should be adopted to facilitate future investigation into the potential prognostic/therapeutic significance of left ventricular endocardial fibroelastosis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据